The US FDA announced an update of testing of NDMA in ranitidine, warning manufacturers not to use a high-temperature test for NDMA as it generates high levels of the impurity.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35ucIOs
via IFTTT
0 comments:
Post a Comment